Pabreca 100 mg Capsule Substitute
Celon Laboratories Pvt Ltd
₹580
(₹27.62 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹3374
(₹160.67 per unit)
Natco Pharma Ltd
₹3750
(₹178.57 per unit)
Cipla Ltd
₹5274.5
(₹251.17 per unit)
Zydus Healthcare Ltd
₹1870
(₹267.14 per unit)
Alkem Laboratories Ltd
₹5683
(₹270.62 per unit)
Wembrace Biopharma Pvt Ltd
₹1899
(₹271.29 per unit)
Sun Pharmaceutical Industries Ltd
₹5717.5
(₹272.26 per unit)
Adley Formulations
₹6270
(₹298.57 per unit)
Glenmark Pharmaceuticals Ltd
₹6400
(₹304.76 per unit)
Intas Pharmaceuticals Ltd
₹7750
(₹369.05 per unit)
Abbott India Ltd
₹17888
(₹851.81 per unit)
Pfizer Ltd
₹21093.5
(₹1004.45 per unit)
Samarth Life Sciences Pvt Ltd
₹22379
(₹1065.67 per unit)
Dr Reddy's Laboratories Ltd
₹95000
(₹4523.81 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Pabreca 100 mg Capsule to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - PALBOCICLIB-100MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Pabreca 100 mg Capsule is used in the treatment of breast cancer. The detailed uses of Pabreca 100 mg Capsule are as follows:
Pabreca 100 mg Capsule helps treat certain types of advanced or metastatic breast cancer by slowing the growth and spread of cancer cells. When used in combination with hormone therapy, it helps control the disease and supports improved treatment outcomes.
Benefits may include:
RX
RX
RX
RX